N-[6-(2-Fluoroanilino)[1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl]-N-(2-fluorophenyl)amine, 98%, 25mg

trans-Cinnamic acid, 99.0%, 1kg

ROTI®Mix PCR 3, 1 ml, 5 x 0,2 ml

5,5'-Dibromo-2,2'-bipyridine, 95.0%, 5g

Methyl 3-ethoxy-4-methoxybenzoate, 95.0%, 5g

Boc-S-tert-butylthio-L-cysteine, 98.0%, 1g

2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, hydrochloride (1:1), 25g

N-(2-Hydroxyethyl)nitotinamide, 95.0%, 1g

Methyl (4-cyanophenyl)acetate, 95.0%, 25g

tert-Butyl 2-(4-oxopiperidin-1-yl)acetate, 95.0%, 1g

tert-Butyl ((4-carbamothioylthiazol-2-yl)methyl)carbamate, 98%, 5g

(2,1,3-Benzothiadiazol-4-yl)methanamine hydrochloride, 95+%, 2.5g

5,6-Dihydro-1H-imidazo[1,2-a]imidazole, 97%, 1g